Research Field

Sitting Down With… Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.

A new method for discovering antibiotics makes use of an unusual source of complex microbial communities: bear saliva.

Could activated T cells play a major role in driving neurodegeneration in glaucoma?

A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality

A simple yet accurate model could help streamline ROP screening

Regulators step in to stop stem cell clinics from marketing unproven therapies.

Introducing the easy-to-use system that offers patients lower risks of complications – regardless of surgeon experience

Researchers identified the cell types associated with schizophrenia mutations

With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease?